These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 17705214)

  • 1. Applying quantitative methods for detecting new drug safety signals in pharmacovigilance national database.
    Shalviri G; Mohammad K; Majdzadeh R; Gholami K
    Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1136-40. PubMed ID: 17705214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New guideline for tramadol usage following adverse drug reactions reported to the Iranian Pharmacovigilance Center.
    Gholami K; Shalviri G; Zarbakhsh A; Daryabari N; Yousefian S
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):229-37. PubMed ID: 17063533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions.
    van Puijenbroek EP; Bate A; Leufkens HG; Lindquist M; Orre R; Egberts AC
    Pharmacoepidemiol Drug Saf; 2002; 11(1):3-10. PubMed ID: 11998548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential utility of data-mining algorithms for early detection of potentially fatal/disabling adverse drug reactions: a retrospective evaluation.
    Hauben M; Reich L
    J Clin Pharmacol; 2005 Apr; 45(4):378-84. PubMed ID: 15778418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Under-reporting of serious adverse drug reactions in Sweden.
    Bäckström M; Mjörndal T; Dahlqvist R
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):483-7. PubMed ID: 15269932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: A study from the French PharmacoVigilance Database.
    Michenot F; Sommet A; Bagheri H; Lapeyre-Mestre M; Montastruc JL;
    Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):735-40. PubMed ID: 16924603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous reporting of adverse drug reactions by nurses.
    Bäckström M; Mjörndal T; Dahlqvist R
    Pharmacoepidemiol Drug Saf; 2002 Dec; 11(8):647-50. PubMed ID: 12512239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of measures of disproportionality for signal detection on adverse drug reaction spontaneous reporting database of Guangdong province in China.
    Li C; Xia J; Deng J; Jiang J
    Pharmacoepidemiol Drug Saf; 2008 Jun; 17(6):593-600. PubMed ID: 18432629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postmarketing hepatic adverse event experience with PEGylated/non-PEGylated drugs: a disproportionality analysis.
    Hauben M; Vegni F; Reich L; Younus M
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):934-41. PubMed ID: 18049161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse events induced by ceftriaxone: a 10-year review of reported cases to Iranian Pharmacovigilance Centre.
    Shalviri G; Yousefian S; Gholami K
    J Clin Pharm Ther; 2012 Aug; 37(4):448-51. PubMed ID: 22122488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital.
    Lugardon S; Desboeuf K; Fernet P; Montastruc JL; Lapeyre-Mestre M
    Br J Clin Pharmacol; 2006 Aug; 62(2):225-31. PubMed ID: 16842398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal detection of methylphenidate by comparing a spontaneous reporting database with a claims database.
    Kim J; Kim M; Ha JH; Jang J; Hwang M; Lee BK; Chung MW; Yoo TM; Kim MJ
    Regul Toxicol Pharmacol; 2011 Nov; 61(2):154-60. PubMed ID: 21510997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse drug reaction reporting by nurses: analysis of Italian pharmacovigilance database.
    Conforti A; Opri S; D'Incau P; Sottosanti L; Moretti U; Ferrazin F; Leone R
    Pharmacoepidemiol Drug Saf; 2012 Jun; 21(6):597-602. PubMed ID: 22337264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of disproportionality analysis methods in national adverse drug reaction databases of China.
    Hou Y; Ye X; Wu G; Cheng G; Du X; He J
    Expert Opin Drug Saf; 2014 Jul; 13(7):853-7. PubMed ID: 24918197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of adverse reactions to nefopam: an analysis of the French Pharmacovigilance database.
    Durrieu G; Olivier P; Bagheri H; Montastruc JL;
    Fundam Clin Pharmacol; 2007 Oct; 21(5):555-8. PubMed ID: 17868209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Data-mining analyses of pharmacovigilance signals in relation to relevant comparison drugs.
    Bate A; Lindquist M; Orre R; Edwards IR; Meyboom RH
    Eur J Clin Pharmacol; 2002 Oct; 58(7):483-90. PubMed ID: 12389072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing data mining methods on the VAERS database.
    Banks D; Woo EJ; Burwen DR; Perucci P; Braun MM; Ball R
    Pharmacoepidemiol Drug Saf; 2005 Sep; 14(9):601-9. PubMed ID: 15954077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of computer-aided disproportionality analysis for post-marketing signal detection.
    Lehman HP; Chen J; Gould AL; Kassekert R; Beninger PR; Carney R; Goldberg M; Goss MA; Kidos K; Sharrar RG; Shields K; Sweet A; Wiholm BE; Honig PK
    Clin Pharmacol Ther; 2007 Aug; 82(2):173-80. PubMed ID: 17507922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nurses are increasingly involved in pharmacovigilance in Sweden.
    Ulfvarson J; Mejyr S; Bergman U
    Pharmacoepidemiol Drug Saf; 2007 May; 16(5):532-7. PubMed ID: 17072915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A knowledge based approach for automated signal generation in pharmacovigilance.
    Henegar C; Bousquet C; Lillo-Le Louët A; Degoulet P; Jaulent MC
    Stud Health Technol Inform; 2004; 107(Pt 1):626-30. PubMed ID: 15360888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.